Download PDF
Aktuelle Dermatologie 2015; 41(07): 288-293
DOI: 10.1055/s-0034-1391887
Eine Klinik im Blickpunkt
© Georg Thieme Verlag KG Stuttgart · New York

Molekularbiologie primär kutaner B-Zell-Lymphome

Molecular Biology of Cutaneous B-Cell-Lymphoma
K. M. Kaune
Klinik für Dermatologie und Allergologie, Klinikum Bremen-Mitte
› Author Affiliations
Further Information

Publication History

Publication Date:
23 April 2015 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Das primär kutane Keimzentrums-Lymphom und das primär kutane Marginalzonen-B-Zell-Lymphom haben eine sehr gute Prognose, wohingegen das primär kutane großzellige B-Zell-Lymphom vom Bein-Typ eine aggressivere Lymphom-Entität darstellt. In den letzten Jahren haben molekulare Studien eine Reihe von genetischen Veränderungen aufgedeckt, welche die Subgruppen der primär kutanen B-Zell-Lymphome voneinander unterscheiden. Während das primär kutane großzellige B-Zell-Lymphom vom Bein-Typ ein ähnliches Muster chromosomaler Aberrationen wie das nodale diffus-großzellige B-Zell-Lymphom hat, weisen das primär kutane Keimzentrums-Lymphom und das primär kutane Marginalzonen-B-Zell-Lymphom große Unterschiede zu dem systemischen follikulären Lymphom bzw. dem systemischen Marginalzonen-B-Zell-Lymphom vom MALT-Typ auf.

Abstract

Primary cutaneous follicle centre lymphoma (PCFCL) and primary cutaneous marginal zone B-cell lymphoma (PCMZL) have an excellent prognosis whereas primary cutaneous large B-cell lymphoma, leg type (PCLBCL, LT) represents a more aggressive lymphoma. In recent years molecular studies have revealed a series of genetic aberrations, which distinguish the subgroups of primary cutaneous B-cell lymphomas. While PCLBCL, LT display a pattern of chromosomal aberrations similar to their systemic counterpart, PCFCL and PCMZL normally lack these typical chromosomal aberrations.

 

  • Literatur

  • 1 Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785
    CrossrefPubMedGoogle Scholar
  • 2 Senff NJ, Hoefnagel JJ, Jansen PM et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007; 25: 1581-1587
    CrossrefPubMedGoogle Scholar
  • 3 Siebert R, Weber-Matthiesen K. Fluorescence in situ hybridization as a diagnostic tool in malignant lymphomas. Histochem Cell Biol 1997; 108: 391-402
    CrossrefPubMedGoogle Scholar
  • 4 Bentz M, Döhner H, Werner CA et al. Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization. Stem Cells 1995; 13 (Suppl. 03) 83-87
    CrossrefPubMedGoogle Scholar
  • 5 Swerdlow SH, Campo E, Harris NL et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th. ed. Lyon, France: IARC Press; 2008
    Google Scholar
  • 6 Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2000; 96: 808-822
    PubMedGoogle Scholar
  • 7 Kim BK, Surti U, Pandya AG et al. Primary and secondary cutaneous diffuse large B-cell lymphomas: A multiparameter analysis of 25 cases including fluorescence in situ hybridization for t(14;18) translocation. Am J Surg Pathol 2003; 27: 356-364
    CrossrefPubMedGoogle Scholar
  • 8 Hallermann C, Kaune KM, Gesk S et al. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol 2004; 123: 213-219
    CrossrefPubMedGoogle Scholar
  • 9 Abdul-Wahab A, Tang SY, Robson A et al. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis. J Am Acad Dermatol 2014; 70: 1010-1020
    CrossrefPubMedGoogle Scholar
  • 10 Mao X, Lillington D, Child F et al. Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 2002; 35: 144-155
    CrossrefPubMedGoogle Scholar
  • 11 Hallermann C, Kaune KM, Siebert R et al. Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas. J Invest Dermatol 2004; 122: 1495-1502
    CrossrefPubMedGoogle Scholar
  • 12 Giménez S, Costa C, Espinet B et al. Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas. Exp Dermatol 2005; 14: 883-890
    CrossrefPubMedGoogle Scholar
  • 13 Dijkman R, Tensen CP, Jordanova ES et al. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J Clin Oncol 2006; 24: 296-305
    PubMedGoogle Scholar
  • 14 Höglund M, Sehn L, Connors JM et al. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer 2004; 39: 195-204
    CrossrefPubMedGoogle Scholar
  • 15 Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511
    CrossrefPubMedGoogle Scholar
  • 16 Hoefnagel JJ, Dijkman R, Basso K et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 2005; 105: 3671-3678
    CrossrefPubMedGoogle Scholar
  • 17 Streubel B, Lamprecht A, Dierlamm J et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003; 101: 2335-2339
    CrossrefPubMedGoogle Scholar
  • 18 Murga Penas EM, Hinz K, Röser K et al. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas. Leukemia 2003; 17: 2225-2229
    CrossrefPubMedGoogle Scholar
  • 19 Espinet B, Gallardo F, Pujol RM et al. Absence of MALT1 translocations in primary cutaneous marginal zone B-cell lymphoma. Haematologica 2004; 89: 14
    PubMedGoogle Scholar
  • 20 Palmedo G, Hantschke M, Rütten A et al. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?. Am J Dermatopathol 2007; 29: 231-236
    CrossrefPubMedGoogle Scholar
  • 21 Belaud-Rotureau MA, Marietta V, Vergier B et al. Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas. Virchows Arch 2008; 452: 607-620
    CrossrefPubMedGoogle Scholar
  • 22 Pham-Ledard A, Prochazkova-Carlotti M, Andrique L et al. Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma. Mod Pathol 2014; 27: 402-411
    PubMedGoogle Scholar
  • 23 Lenz G, Wright GW, Emre NC et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 2008; 105: 13520-13525
    CrossrefPubMedGoogle Scholar
  • 24 Du M, Peng H, Singh N et al. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 1995; 86: 4587-4593
    PubMedGoogle Scholar
  • 25 Pinyol M, Cobo F, Bea S et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998; 91: 2977-2984
    PubMedGoogle Scholar
  • 26 Møller MB, Kania PW, Ino Y et al. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A. Leukemia 2000; 14: 898-904
    CrossrefPubMedGoogle Scholar
  • 27 Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 2006; 7: 667-677
    CrossrefPubMedGoogle Scholar
  • 28 Polager S, Ginsberg D. p53 and E2f: partners in life and death. Nat Rev Cancer 2009; 9: 738-748
    CrossrefPubMedGoogle Scholar
  • 29 Kaune KM, Neumann C, Hallermann C et al. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas. Exp Dermatol 2011; 20: 331-335
    CrossrefPubMedGoogle Scholar
  • 30 Senff NJ, Zoutman WH, Vermeer MH et al. Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. J Invest Dermatol 2009; 129: 1149-1155
    CrossrefPubMedGoogle Scholar
  • 31 Wiesner T, Streubel B, Huber D et al. Genetic aberrations in primary cutaneous large B-cell lymphoma: a fluorescence in situ hybridization study of 25 cases. Am J Surg Pathol 2005; 29: 666-673
    CrossrefPubMedGoogle Scholar